WHO and European Commission representatives, entrepreneurs and scientists meet in Lyon on April 15-16, 2015
Lyon, France, March 5, 2015 – BIOVISION, the annual forum for life science forecasting, is pleased to release the 2015 event program with key speakers for this year’s conference.
The opening session will feature Professor Leroy Hood, from the Institute for Systems Biology (USA). This discussion centers on how to ensure that global healthcare and personalized medicine is accessible to all.
Professor Guillaume Beslon, INRIA (France), and Dr. Pascal Sempé (France), an IBM representative, will use the session ‘From Big Data to Smart Data’ to assess the implications of this new approach in healthcare.
Michel G. Bergeron of Centre de Recherche en Infectiologie de l’Université Laval Research (Quebec City, Canada), is also speaking at the ‘Big data’ session. He says: “We are currently working on a simple device based on DNA testing that will allow us to diagnose any known infection in less than one hour. This device could be used directly with the patient, meaning it will be ideal in emergency situations or in areas with limited access to healthcare.”
In the ‘Models for Customized Approaches’ session, Dr. Alain Beaudet, president of the Canadian Institutes of Health Research, Agnès Buzyn, president of INCa (France), and Professor Peter Openshaw of Imperial College London (UK) will each address the topic of personalized medicine, which offers a wide range of applications, particularly in the fields of oncology and infectious diseases.
Among the speakers lined up for the session on ‘Ethics, Regulatory and Economic Perspectives on Access for Customized Approaches’, of particular note are Professor Hervé Chneiweiss from Inserm (France) and Greg Perry from the Medicines Patent Pool (Switzerland).
At the closing session, Professor Ole Petter Ottersen, chancellor of the University of Oslo (Norway), will share his views on research and innovation in this sector. His talk will highlight how global healthcare and personalized medicine can be beneficial for all and a driving force for growth.
“The personalized healthcare approach will ultimately be part of an overarching patient-centered healthcare process, where the benefits and risks plus ethical, socioeconomic and organizational problems are fully understood,” said Didier Hoch, president of BIOVISION. “This approach will go hand in hand with a real transformation - a revolution - of healthcare, from which everyone stands to benefit.”
This year one of the plenary sessions will be open to the public – ‘Global and Personalized Health: How to ensure a worldwide benefit?’. Speakers at this session will include Philippe Douste-Blazy, a former minister and chair of UNITAID (Switzerland), and Professor Jean-Marie Lehn, Nobel Prize winner, from the University of Strasbourg (France).
This public conference is free on registration. For further information, please go to www.biovision.org
Introducing an additional web conference on Thursday March 26, 11am CET: This online presentation covers the ten rules for a successful pitch and announces all of the selected companies for the BIOVISION Investor Conference and BIOVISION Catalyzer pitch competition.
Sign up to receive the BIOVISION newsletter – Media accreditation is here
Follow us on Twitter: @BIOVISIONForum - #Biovision2015
Practical information
April 15 from 2:00 pm and April 16 from 9:30 am (CET)
BIOVISION
Palais des Congrès – Cité internationale de Lyon
50 Quai Charles de Gaulle
69006 Lyon, France
Public transport:
Line C1: a 12-minute trolleybus journey connects Lyon’s Cité internationale with the Gare de la Part-Dieu train station.
Line 4: connections to metro lines A (Foch) and D (Saxe - Gambetta).
Line 58: direct connections to Presqu’île and Place Bellecour.
By road:
The Cité internationale is located close to the northern ring road; take the Porte de St Clair exit towards Cité internationale. Autoroutes: A6 - Paris, A7 – Marseille, A42- Genève, A43 - Chambéry – Grenoble
About BIOVISION
BIOVISION is an international forum devoted to the life sciences. The aim is to discuss forward-looking opportunities and to facilitate collaboration between the various stakeholders, to encourage innovation and ultimately ensure public access to knowledge and solutions. Founded in 1999, BIOVISION is driven by an independent not-for-profit organization, the Foundation for the University of Lyon in France (the Fondation pour l’Université de Lyon.)
The forum has a global reach and brings together a large number of leading figures every year in Lyon. Participants include researchers, policy-makers, investors and entrepreneurs; from startups to multinationals. Together, these multidisciplinary decision-makers reflect on the future advances in life sciences and consult on how to convert discoveries by researchers into practical, innovative solutions with a public health benefit. They directly address business models and funding solutions.
To foster innovation, BIOVISION has introduced two themed sessions where project owners and leaders of innovative start-ups can pitch their vision.
The BIOVISION Catalyzer is organized jointly with Lyonbiopôle, a world competitiveness cluster in the field of life sciences, to promote projects originating from public-private partnerships.
The BIOVISION Investor Conference is organized jointly with Lyonbiopôle and France Biotech to discuss funding and identify promising start-ups and innovative companies.
An online networking platform and on-site meeting areas foster and support these discussions.
BIOVISION also hosts live streamed sessions to raise awareness and engage communities in scientific issues around the health care challenges of tomorrow.
BIOVISION enjoys the support of the Greater Lyon and the Rhône-Alpes Region.
More information
About the Fondation pour l’Université de Lyon
Chaired by Alain Mérieux, the purpose of the Fondation is to support the University of Lyon in its ambition to be one of Europe’s ten largest higher education and research clusters. The seven active founders of the Fondation (banking group BNP Paribas, the French Deposits and Consignments Fund, CIC bank, retailer Casino, the Institut Mérieux, pharmaceutical group Sanofi and Lyon-based domestic appliance manufacturer SEB) help it to fulfill its remit of promoting the international recognition of the University of Lyon, contributing to its excellence and strengthening its ties with the territory. For the Fondation, BIOVISION is a key element of the region’s international profile in one of its areas of excellence; the life sciences. The forum also contributes directly to the economic development of the area through innovation.
Help employers find you! Check out all the jobs and post your resume.
Lyon, France, March 5, 2015 – BIOVISION, the annual forum for life science forecasting, is pleased to release the 2015 event program with key speakers for this year’s conference.
The opening session will feature Professor Leroy Hood, from the Institute for Systems Biology (USA). This discussion centers on how to ensure that global healthcare and personalized medicine is accessible to all.
Professor Guillaume Beslon, INRIA (France), and Dr. Pascal Sempé (France), an IBM representative, will use the session ‘From Big Data to Smart Data’ to assess the implications of this new approach in healthcare.
Michel G. Bergeron of Centre de Recherche en Infectiologie de l’Université Laval Research (Quebec City, Canada), is also speaking at the ‘Big data’ session. He says: “We are currently working on a simple device based on DNA testing that will allow us to diagnose any known infection in less than one hour. This device could be used directly with the patient, meaning it will be ideal in emergency situations or in areas with limited access to healthcare.”
In the ‘Models for Customized Approaches’ session, Dr. Alain Beaudet, president of the Canadian Institutes of Health Research, Agnès Buzyn, president of INCa (France), and Professor Peter Openshaw of Imperial College London (UK) will each address the topic of personalized medicine, which offers a wide range of applications, particularly in the fields of oncology and infectious diseases.
Among the speakers lined up for the session on ‘Ethics, Regulatory and Economic Perspectives on Access for Customized Approaches’, of particular note are Professor Hervé Chneiweiss from Inserm (France) and Greg Perry from the Medicines Patent Pool (Switzerland).
At the closing session, Professor Ole Petter Ottersen, chancellor of the University of Oslo (Norway), will share his views on research and innovation in this sector. His talk will highlight how global healthcare and personalized medicine can be beneficial for all and a driving force for growth.
“The personalized healthcare approach will ultimately be part of an overarching patient-centered healthcare process, where the benefits and risks plus ethical, socioeconomic and organizational problems are fully understood,” said Didier Hoch, president of BIOVISION. “This approach will go hand in hand with a real transformation - a revolution - of healthcare, from which everyone stands to benefit.”
This year one of the plenary sessions will be open to the public – ‘Global and Personalized Health: How to ensure a worldwide benefit?’. Speakers at this session will include Philippe Douste-Blazy, a former minister and chair of UNITAID (Switzerland), and Professor Jean-Marie Lehn, Nobel Prize winner, from the University of Strasbourg (France).
This public conference is free on registration. For further information, please go to www.biovision.org
Introducing an additional web conference on Thursday March 26, 11am CET: This online presentation covers the ten rules for a successful pitch and announces all of the selected companies for the BIOVISION Investor Conference and BIOVISION Catalyzer pitch competition.
Sign up to receive the BIOVISION newsletter – Media accreditation is here
Follow us on Twitter: @BIOVISIONForum - #Biovision2015
Practical information
April 15 from 2:00 pm and April 16 from 9:30 am (CET)
BIOVISION
Palais des Congrès – Cité internationale de Lyon
50 Quai Charles de Gaulle
69006 Lyon, France
Public transport:
Line C1: a 12-minute trolleybus journey connects Lyon’s Cité internationale with the Gare de la Part-Dieu train station.
Line 4: connections to metro lines A (Foch) and D (Saxe - Gambetta).
Line 58: direct connections to Presqu’île and Place Bellecour.
By road:
The Cité internationale is located close to the northern ring road; take the Porte de St Clair exit towards Cité internationale. Autoroutes: A6 - Paris, A7 – Marseille, A42- Genève, A43 - Chambéry – Grenoble
About BIOVISION
BIOVISION is an international forum devoted to the life sciences. The aim is to discuss forward-looking opportunities and to facilitate collaboration between the various stakeholders, to encourage innovation and ultimately ensure public access to knowledge and solutions. Founded in 1999, BIOVISION is driven by an independent not-for-profit organization, the Foundation for the University of Lyon in France (the Fondation pour l’Université de Lyon.)
The forum has a global reach and brings together a large number of leading figures every year in Lyon. Participants include researchers, policy-makers, investors and entrepreneurs; from startups to multinationals. Together, these multidisciplinary decision-makers reflect on the future advances in life sciences and consult on how to convert discoveries by researchers into practical, innovative solutions with a public health benefit. They directly address business models and funding solutions.
To foster innovation, BIOVISION has introduced two themed sessions where project owners and leaders of innovative start-ups can pitch their vision.
The BIOVISION Catalyzer is organized jointly with Lyonbiopôle, a world competitiveness cluster in the field of life sciences, to promote projects originating from public-private partnerships.
The BIOVISION Investor Conference is organized jointly with Lyonbiopôle and France Biotech to discuss funding and identify promising start-ups and innovative companies.
An online networking platform and on-site meeting areas foster and support these discussions.
BIOVISION also hosts live streamed sessions to raise awareness and engage communities in scientific issues around the health care challenges of tomorrow.
BIOVISION enjoys the support of the Greater Lyon and the Rhône-Alpes Region.
More information
About the Fondation pour l’Université de Lyon
Chaired by Alain Mérieux, the purpose of the Fondation is to support the University of Lyon in its ambition to be one of Europe’s ten largest higher education and research clusters. The seven active founders of the Fondation (banking group BNP Paribas, the French Deposits and Consignments Fund, CIC bank, retailer Casino, the Institut Mérieux, pharmaceutical group Sanofi and Lyon-based domestic appliance manufacturer SEB) help it to fulfill its remit of promoting the international recognition of the University of Lyon, contributing to its excellence and strengthening its ties with the territory. For the Fondation, BIOVISION is a key element of the region’s international profile in one of its areas of excellence; the life sciences. The forum also contributes directly to the economic development of the area through innovation.
Help employers find you! Check out all the jobs and post your resume.
